A nurse is caring for a patient who received an allogeneic hematopoietic stem cell transplant 14 days ago. The patient develops a maculopapular rash on the palms and soles, persistent diarrhea (>500 mL/day), and elevated liver enzymes (ALT 180 U/L, AST 165 U/L). What is the priority nursing intervention?

Acute GVHD with skin, GI, and liver involvement is life-threatening and requires immediate immunosuppressive therapy to prevent organ damage. Other options are supportive but secondary.

Core Nursing Explanation Key Concept Analysis: This question assesses the recognition and priority management of Acute Graft-versus-Host Disease (aGVHD) following an allogeneic hematopoietic stem cell transplant (HSCT). The classic triad of symptoms—maculopapular rash (skin), persistent diarrhea (gastrointestinal), and elevated liver enzymes (liver)—is diagnostic for aGVHD. This is an immune-mediated condition where donor T-cells attack the recipient's (host's) tissues. It is a medical emergency that can rapidly progress to multi-organ failure and death if not treated aggressively.

Answer Rationale: Key Point! The priority nursing intervention is to administer prescribed immunosuppressive therapy and monitor for infection. The primary goal is to halt the immune attack on the host organs. High-dose corticosteroids (e.g., methylprednisolone) are the first-line treatment. While administering this therapy, the nurse must vigilantly monitor for signs of infection because immunosuppressive drugs further suppress an already immunocompromised patient, creating a high risk for sepsis.

Distractor Analysis:
Watch out for confusion! Option ② (Increase fluid intake and provide electrolyte replacement) addresses the symptoms (diarrhea) but not the root cause. While fluid and electrolyte management is a critical supportive intervention, it is secondary to initiating the definitive treatment that will stop the diarrhea.
Option ③ (Apply topical corticosteroids) is too narrow. Topical steroids may be used for mild, isolated skin GVHD, but this patient has multi-organ involvement (skin, GI, liver), indicating moderate-to-severe disease that requires systemic immunosuppression.
Option ④ (Implement strict isolation) is incorrect. While the patient is immunocompromised and needs protective isolation (neutropenic precautions), the development of aGVHD itself is not an infectious process that requires isolating the patient from others to protect them. The priority is treating the life-threatening immune reaction.

Related Concepts: Understanding the grading of aGVHD (Grade I-IV) based on organ involvement is crucial for anticipating nursing care needs. Nurses must also balance aggressive immunosuppression with infection prevention strategies (e.g., meticulous hand hygiene, monitoring for fever, avoiding fresh flowers/fruits). Concept Summary

Concept	Key Points
Acute GVHD (aGVHD)	Immune attack by donor cells post-transplant. Classic triad: Skin rash, GI (diarrhea), Liver (elevated enzymes).
Priority Intervention	Immediate administration of systemic immunosuppressive therapy (e.g., corticosteroids).
Nursing Role	Administer meds, monitor for therapeutic response & side effects (especially infection), provide supportive care (skin, fluid, nutrition).
Timing	Typically occurs within first 100 days post-transplant. Onset at day 14 is classic.

Side-by-Side Comparison!

Condition	Acute GVHD (aGVHD)	Infection in Immunocompromised Host
Pathophysiology	Donor T-cells attack host organs (skin, GI, liver).	Bacteria, virus, or fungus invades due to lack of neutrophils/immune function.
Key Symptoms	Triad: Rash (palms/soles), watery diarrhea, jaundice/elevated LFTs.	Fever, chills, localized signs (e.g., cough, dysuria), but may be subtle.
Priority Action	Start immunosuppressants to stop immune attack.	Obtain cultures & start broad-spectrum antibiotics STAT.
Isolation Need	Protective isolation (for patient).	Protective isolation (for patient). May need contact/isolation if specific pathogen.

Anatomy, Physiology & Pharmacology Points

• Pathophysiology: In aGVHD, donor T-cells recognize host tissues as "foreign" and mount an inflammatory attack. Cytokine release damages epithelial cells of skin, intestinal mucosa, and bile ducts.
• Pharmacology: First-line drugs are corticosteroids (prednisone, methylprednisolone). They work by suppressing T-cell activation and cytokine production. Second-line agents include calcineurin inhibitors (tacrolimus, cyclosporine) and monoclonal antibodies.
• Lab Values: Elevated liver enzymes: ALT 180 U/L (Normal: ~40 U/L), AST 165 U/L (Normal: ~40 U/L). Diarrhea volume > 500 mL/day indicates significant GI involvement.

Memory Tips

• Acronym "SGL" for aGVHD Triad: Skin, Gut, Liver.
• Timing: Think "Acute = First 100 days". Day 14 is a classic presentation window.
• Priority: "Stop the Attack!" -> Immunosuppressants first, supportive care second.

High-Frequency NCLEX Topics The NCLEX loves to test priority-setting in oncology and transplant nursing. aGVHD is a classic "priority intervention" question. Remember: Life-threatening condition + definitive treatment exists = Administer that treatment as the priority. Also be ready to differentiate aGVHD symptoms from infection or chemotherapy side effects.

Watch Out for Question Variations!

• Symptom Identification: "A patient post-allogeneic HSCT has a rash on palms and nausea. The nurse should suspect..." (Answer: aGVHD).
• Patient Education: "What should the nurse teach a patient to report immediately after discharge post-transplant?" (Answer: New rash, diarrhea, yellowing of skin).
• Medication Teaching: "A patient on cyclosporine for GVHD prophylaxis develops tremors and hypertension. The nurse interprets this as..." (Answer: Side effects of calcineurin inhibitor).

Nursing Clinical Practice Guide Clinical Scenario: You are the nurse on the bone marrow transplant unit. Your patient, Mr. Chen, who received a transplant from his brother two weeks ago, calls you to his room. He shows you a new red, bumpy rash on his palms and complains of severe abdominal cramps and 8 episodes of watery diarrhea in the last 12 hours. He feels weak and fatigued.

Nursing Intervention Strategy:

1. Immediate Assessment (ABCs first): Assess vital signs for fever (infection risk) and hypotension (from fluid loss). Perform a focused skin assessment (document rash distribution, character), abdominal assessment, and measure stool output/character.
2. Notify the Provider STAT: Report your findings: "Patient post-day +14 allogeneic HSCT presenting with new maculopapular rash on palms/soles, >500 mL diarrhea, complaining of cramps. Suspect acute GVHD."
3. Priority Implementation: Once the provider orders IV methylprednisolone, administer it promptly. Ensure double-check of the dose due to high potency.
4. Concurrent Supportive Care:
   • Fluid & Electrolytes: Initiate IV hydration per protocol. Monitor I&O strictly. Replace potassium and magnesium as ordered (lost in diarrhea).
   • Skin Care: Use mild, fragrance-free soap and emollients. Keep skin clean and dry. Avoid scratching.
   • Nutrition: Collaborate with dietitian. May need TPN (Total Parenteral Nutrition) if oral intake is poor due to GI involvement.
5. Monitoring & Evaluation: Monitor for response to steroids (decrease in rash, diarrhea volume). Critically monitor for infection (fever, chills, change in mental status, new cough) as steroids increase immunosuppression.

Patient Safety and Precautions:

• Infection Prevention: Maintain strict neutropenic precautions (private room, HEPA filter, no fresh fruits/vegetables, meticulous hand hygiene by all).
• Medication Safety: Corticosteroids can cause hyperglycemia, mood changes, and insomnia. Monitor blood glucose. Tacrolimus/Cyclosporine levels must be monitored to avoid toxicity (nephrotoxicity, neurotoxicity).
• Fluid Balance: Weigh patient daily. Rapid fluid shifts can occur.

Nursing Procedure & Medication Flow Administering IV Methylprednisolone for aGVHD:

1. Verify order, patient, and allergy.
2. Prepare medication. Common dose for aGVHD: Methylprednisolone 1-2 mg/kg/day IV. Calculate carefully.
3. Administer via IV pump over 30-60 minutes as per protocol to avoid cardiac irritability.
4. Monitor during infusion for reactions (flushing, tachycardia).
5. Post-administration: Monitor for side effects - hyperglycemia (check blood glucose), fluid retention, mood changes, and increased infection risk.

A Word from Your Senior Nurse "Post-transplant patients are on a tightrope. On one side is graft failure or rejection (GVHD), and on the other is life-threatening infection. Your sharp assessment skills are the safety net. When you see that classic triad, your brain should scream 'GVHD!' and you must act swiftly to get those immunosuppressants on board. But never forget, the moment you give those powerful drugs, you've dialed up the infection risk. Your vigilant monitoring for the slightest sign of fever or change in condition is what protects your patient through this critical time. In nursing, we often fight one problem while guarding against the complication of the treatment. That's the art and science of what we do."